ArticlePLoS neglected tropical diseases2016
Costs of Dengue Control Activities and Hospitalizations in the Public Health Sector during an Epidemic Year in Urban Sri Lanka.
Article in PLoS neglected tropical diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 59 citations in OpenAlex.
- The economic burden of dengue: a systematic literature review of unit costs for non-fatal episodes treated in the formal healthcare system.BMC infectious diseases · 2026Pooled it
- Cost of illness and program of dengue: A systematic review.PloS one · 2019Pooled it
- Role of the dengue vaccine TAK-003 in an outbreak response: Modeling the Sri Lanka experience.PLoS neglected tropical diseases · 2024Trial
- Evaluating the economic burden of dengue in Sri Lanka: A systematic review of costs from 2010 to 2024.IJID regions · 2026Review
- Evaluation of mycoparasiticFrontiers in cellular and infection microbiology · 2025Article
- Upsurge of dengue outbreaks in several WHO regions: Public awareness, vector control activities, and international collaborations are key to prevent spread.Health science reports · 2024Review
- Forecasting weekly dengue incidence in Sri Lanka: Modified Autoregressive Integrated Moving Average modeling approach.PloS one · 2024Article
- Economic burden of dengue in urban Bangladesh: A societal perspective.PLoS neglected tropical diseases · 2023Article
- Laboratory scale evaluation of the feasibility of locally found bladderworts as biological agents to control dengue vector, Aedes aegypti in Sri Lanka.BMC plant biology · 2023Article
- Epidemiological Characteristics and Economic Burden of Dengue in Zhejiang Province, China.Viruses · 2023Article
- Developing African arbovirus networks and capacity strengthening in arbovirus surveillance and response: findings from a virtual workshop.Parasites & vectors · 2023Article
- Development of a machine learning model for early prediction of plasma leakage in suspected dengue patients.PLoS neglected tropical diseases · 2023Article
- Mathematical model and artificial intelligence for diagnosis of Alzheimer's disease.European physical journal plus · 2023Article
- Advancing scalability and impacts of a teacher training program for promoting child mental health in Ugandan primary schools: protocol for a hybrid-type II effectiveness-implementation cluster randomized trial.International journal of mental health systems · 2022Article
- Direct and indirect costs for hospitalized patients with dengue in Southern Sri Lanka.BMC health services research · 2022Article
- Changing epidemiology of dengue in Sri Lanka-Challenges for the future.PLoS neglected tropical diseases · 2021Review
- Predictive value of hepatic transaminases during febrile phase as a predictor of a severe form of Dengue: analysis of adult Dengue patients from a tertiary care setting of Sri Lanka.BMC research notes · 2021Article
- Article
- Cost-effectiveness analysis of VECTOS software for the control of diseases transmitted by Aedes aegypti in two Colombian municipalitiesBiomedica : revista del Instituto Nacional de Salud · 2020Article
- Optimal control approaches for combining medicines and mosquito control in tackling dengue.Royal Society open science · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 5 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundReported as a public health problem since the 1960s in Sri Lanka, dengue has become a high priority disease for public health authorities. The Ministry of Health is responsible for controlling dengue and other disease outbreaks and associated health care. The involvement of large numbers of public health staff in dengue control activities year-round and the provision of free medical care to dengue patients at secondary care hospitals place a formidable financial burden on the public health sector.
methodsWe estimated the public sector costs of dengue control activities and the direct costs of hospitalizations in Colombo, the most heavily urbanized district in Sri Lanka, during the epidemic year of 2012 from the Ministry of Health's perspective. The financial costs borne by public health agencies and hospitals are collected using cost extraction tools designed specifically for the study and analysed retrospectively using a combination of activity-based and gross costing approaches.
resultsThe total cost of dengue control and reported hospitalizations was estimated at US$3.45 million (US$1.50 per capita) in Colombo district in 2012. Personnel costs accounted for the largest shares of the total costs of dengue control activities (79%) and hospitalizations (46%). The results indicated a per capita cost of US$0.42 for dengue control activities. The average costs per hospitalization ranged between US$216-609 for pediatric cases and between US$196-866 for adult cases according to disease severity and treatment setting.
conclusionsThis analysis is a first attempt to assess the economic burden of dengue response in the public health sector in Sri Lanka. Country-specific evidence is needed for setting public health priorities and deciding about the deployment of existing or new technologies. Our results suggest that dengue poses a major economic burden on the public health sector in Sri Lanka.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.